Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Patricia Meaney who wrote (144503)	5/22/2005 8:51:01 PM
From: Jim Bishop	Respond to of 150070

You got it MOARS + MOAFS + MOAFU = MOASS + MOANR = DUMBASS x 3

To: Patricia Meaney who wrote (144503)	5/24/2005 9:45:30 AM
From: dkgross	Read Replies (3) \| Respond to of 150070

SEIH (BSNS WIRE) S3 Investment Company Receives Order from GE Medical Systems for Ulrich Injector System Business Editors TEMECULA, Calif.--(BUSINESS WIRE)--May 24, 2005-- S3 Investment Company (OTCBB:SEIH) today announced that portfolio investment company, SINO UJE, Ltd., has received an order directly from GE Medical Systems for an Ulrich GmbH & Co. injector system. Ulrich (http://www.ulrich-ulm.de/eng/start.html) is a world leader in the design and manufacture of injector systems for medical imaging applications. The order represents an important milestone for SINO UJE as half of all injector orders in China are placed through the CT or MRI original equipment manufacturers (OEM) directly. By receiving this order from a major equipment manufacturer, SINO UJE has established a foothold in the half of the injector market not previously accessed through its distribution network in China. "Ulrich injector systems are used to deliver contrast agents to patients just prior to CT or MRI exams. The contrast agents help facilitate higher resolution images of the patients when they undergo these examinations. The vast majority of CT or MRI examinations are made with the help of contrast agents. GE is the strong market leader in China for medical imaging systems and specifically CT and MRI machines," commented Chris Bickel, chairman and chief executive officer for S3 Investments. "Half of all contrast agent injector systems are sold through the OEMs that in turn deliver the injector system together with the CT or MRI machine to the hospital. Obtaining access to this channel for Ulrich sales is critical to allow SINO UJE to address this 50% of the market." About The Company S3 Investment Company Inc. (http://www.s3investments.com) is a Business Development Company regulated by the Investment Company Act of 1940. Its first operating subsidiary, Securesoft Systems Inc. (http://www.securesoftsystems.com), was acquired in April 2003. S3 Investments has subsequently acquired 100% of Redwood Capital to participate in the fast-growing investment banking market in China and 51% of SINO UJE, a non-stocking distributor of medical and industrial high-tech products to markets throughout China. S3 is currently seeking to acquire additional synergistic companies and is focused on assembling a portfolio of investments that will provide value to its shareholders. Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events. KEYWORD: ASIA PACIFIC NORTH AMERICA CALIFORNIA UNITED STATES CHINA INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PROFESSIONAL SERVICES ACCOUNTING BANKIN CONSULTING FINANCE SOURCE: S3 Investment Company CONTACT INFORMATION: Gemini Financial Communications for S3 Investment Co. A. Beyer, 951-587-8072 investors@s3investments.com * end of story *